Portal Biotechnologies Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$10.5M
- Investors
-
11
Portal Biotechnologies General Information
Description
Developer of a cell-engineering platform designed to support cell-based research, therapeutic development, and biological data generation. The company offers proprietary mechanoporation technology for delivering RNA, proteins, gene-editing tools, and small molecules into primary cells while preserving cell viability and function, enabling pharmaceutical companies, academic hospitals, and cancer research centers to advance drug discovery, cell engineering, and precision medicine research.
Contact Information
Website
www.portal.bioCorporate Office
- 134 Coolidge Avenue
- Watertown, MA 02472
- United States
Corporate Office
- 134 Coolidge Avenue
- Watertown, MA 02472
- United States
Portal Biotechnologies Timeline
Portal Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 29-May-2026 | $10.5M | Completed | Generating Revenue | ||
| 2. Seed Round | 20-Dec-2024 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Portal Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-6 | ||||||||
| Seed-5 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 2,152,971 | $0.000117 | $0.67 | $0.67 | 1x | $0.67 | 2.91% | |
| Seed | 4,320,167 | $0.000117 | $0.58 | $0.58 | 1x | $0.58 | 5.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Portal Biotechnologies Comparisons
Industry
Financing
Details
Portal Biotechnologies Competitors (5)
One of Portal Biotechnologies’s 5 competitors is MaxCyte, a Formerly VC-backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MaxCyte | Formerly VC-backed | Rockville, MD | ||||
| Synthego | Venture Capital-Backed | Redwood City, CA | ||||
| AVECTAS | Venture Capital-Backed | Kildare, Ireland | ||||
| Thermo Fisher Scientific | Formerly PE-Backed | Waltham, MA | ||||
| Lonza Bioscience | Corporation | Colmar, France |
Portal Biotechnologies Patents
Portal Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026207215-A1 | Cellular interaction assays involving delivery of one or more components by mechanoporation | Pending | 26-Mar-2025 | ||
| US-D1154964-S1 | Cell mechanoporation cartridge | Active | 07-May-2024 | ||
| US-D1111186-S1 | Tabletop cell mechanoporation system | Active | 07-May-2024 | ||
| WO-2025128569-A1 | Cell mechanoporation cartridges and methods of use thereof | Inactive | 11-Dec-2023 | ||
| EP-4823755-A1 | High-throughput systems for intracellular delivery and components and uses thereof | Pending | 11-Dec-2023 | B01D63/087 |
Portal Biotechnologies Signals
Portal Biotechnologies Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NFX | Venture Capital | Minority | ||
| TechU Ventures | Venture Capital | Minority | ||
| 10X Capital | Venture Capital | Minority | ||
| Conscience | Venture Capital | Minority | ||
| IA Ventures | Venture Capital | Minority |
Portal Biotechnologies FAQs
-
When was Portal Biotechnologies founded?
Portal Biotechnologies was founded in 2023.
-
Where is Portal Biotechnologies headquartered?
Portal Biotechnologies is headquartered in Watertown, MA.
-
What is the size of Portal Biotechnologies?
Portal Biotechnologies has 25 total employees.
-
What industry is Portal Biotechnologies in?
Portal Biotechnologies’s primary industry is Discovery Tools (Healthcare).
-
Is Portal Biotechnologies a private or public company?
Portal Biotechnologies is a Private company.
-
What is the current valuation of Portal Biotechnologies?
The current valuation of Portal Biotechnologies is .
-
What is Portal Biotechnologies’s current revenue?
The current revenue for Portal Biotechnologies is .
-
How much funding has Portal Biotechnologies raised over time?
Portal Biotechnologies has raised $22.8M.
-
Who are Portal Biotechnologies’s investors?
NFX, TechU Ventures, 10X Capital, Conscience, and IA Ventures are 5 of 11 investors who have invested in Portal Biotechnologies.
-
Who are Portal Biotechnologies’s competitors?
MaxCyte, Synthego, AVECTAS, Thermo Fisher Scientific, and Lonza Bioscience are competitors of Portal Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process